Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)
J Gynecol Oncol
.
2016 Jul;27(4):e36.
doi: 10.3802/jgo.2016.27.e36.
Epub 2016 Mar 30.
Authors
Min Chul Choi
1
,
Myong Cheol Lim
2
,
Dong Hoon Suh
3
,
Yong Jung Song
4
,
Tae Joong Kim
5
,
Suk Joon Chang
6
,
Jae Weon Kim
7
;
Korean Society of Gynecologic Oncology
Affiliations
1
Comprehensive Gynecologic Cancer Center, Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
2
Center for Uterine Cancer, National Cancer Center, Goyang, Korea. gynlim@gmail.com.
3
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
4
Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
5
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
6
Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
7
Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
PMID:
27102245
PMCID:
PMC4864512
DOI:
10.3802/jgo.2016.27.e36
No abstract available
MeSH terms
Fallopian Tube Neoplasms / genetics*
Female
Genes, BRCA1
Genes, BRCA2
Genetic Testing*
Humans
Mutation
Ovarian Neoplasms / genetics*
Peritoneal Neoplasms / genetics*
Republic of Korea
Societies, Medical